Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Cardiosphere-derived cells (CDCs) ameliorate skeletal and cardiac muscle deterioration in experimental models of Duchenne muscular dystrophy. The HOPE-2 trial examined the safety and efficacy of sequential intravenous infusions of human allogeneic CDCs in late-stage Duchenne muscular dystrophy.

Gespeichert in:
Autor*in:

McDonald, Craig M [verfasserIn]

Marbán, Eduardo

Hendrix, Suzanne

Hogan, Nathaniel

Ruckdeschel Smith, Rachel

Eagle, Michelle

Finkel, Richard S

Tian, Cuixia

Janas, Joanne

Harmelink, Matthew M

Varadhachary, Arun S

Taylor, Michael D

Hor, Kan N

Mayer, Oscar H

Henricson, Erik K

Furlong, Pat

Ascheim, Deborah D

Rogy, Siegfried

Williams, Paula

Marbán, Linda

Butterfield, Russell

Connolly, Anne

Muntoni, Francesco

Joyce, Nanette C.

Evans, Maya

Abedi, Mehrdad

Surampudi, Prasanth

Jhawar, Sanjay

Dayan, Jonathan G.

Anthonisen, Colleen

Goude, Erica

Nicorici, Alina

Sarwary, Omaid

Prasad, Poonam

Baek, Jayoon

Newton, Andrew

Johnson, Hannah

Kusmik, Kyle

Filar, Lauri

Edmondson, Angie

Rybalsky, Irina

Chouteau, Wendy

Giordano, Anthony F.

Rodriguez, Aixa

Anderson, Kristan

Wezel, Germaine

Vega, Melisa

Duke, Julie

Collado, Jorge

Civitello, Matthew

Wells, Julie

Pyzik, Erika

Rehborg, Rebecca

Brown, Michelle

Van Eyk, Jennifer

Rogers, Russell G.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Umfang:

10

Übergeordnetes Werk:

Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.]

Übergeordnetes Werk:

volume:399 ; year:2022 ; number:10329 ; day:12 ; month:03 ; pages:1049-1058 ; extent:10

Links:

Volltext

DOI / URN:

10.1016/S0140-6736(22)00012-5

Katalog-ID:

ELV05709036X

Nicht das Richtige dabei?

Schreiben Sie uns!